Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Oesch, F; Herrero, M E; Hengstler, J G; Lohmann, M; Arand, M (2000). Metabolic detoxification: implications for thresholds. Toxicologic pathology, 28(3):382-387.

Hengstler, J G; Lange, J; Kett, A; Dornhöfer, N; Meinert, R; Arand, M; Knapstein, P G; Becker, R; Oesch, F; Tanner, B (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. Cancer Research, 59(13):3206-3214.

Hengstler, J G; Kett, A; Arand, M; Oesch-Bartlomowicz, B; Oesch, F; Pilch, H; Tanner, B (1998). Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Letters, 130(1-2):43-48.

Tanner, B; Hengstler, J G; Luch, A; Meinert, R; Kreutz, E; Arand, M; Wilkens, C; Hofmann, M; Oesch, F; Knapstein, P G; Becker, R (1998). C-myc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type. International Journal of Gynecological Pathology, 17(1):66-74.

Herrero, M E; Arand, M; Hengstler, J G; Oesch, F (1997). Recombinant expression of human microsomal epoxide hydrolase protects V79 Chinese hamster cells from styrene oxide- but not from ethylene oxide-induced DNA strand breaks. Environmental and Molecular Mutagenesis, 30(4):429-439.

Oesch, F; Hengstler, J G; Arand, M; Fuchs, J (1995). Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapy. Pharmacogenetics, 5 Spec N:S118-S122.

This list was generated on Fri Apr 19 19:09:18 2019 CEST.